It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DHR’s FA Score shows that 1 FA rating(s) are green whileSMLR’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DHR’s TA Score shows that 3 TA indicator(s) are bullish while SMLR’s TA Score has 4 bullish TA indicator(s).
DHR (@Medical Specialties) experienced а -0.11% price change this week, while SMLR (@Medical Specialties) price change was -5.04% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +1.26%. For the same industry, the average monthly price growth was -6.26%, and the average quarterly price growth was -7.76%.
DHR is expected to report earnings on Oct 19, 2023.
SMLR is expected to report earnings on Oct 31, 2023.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
|DHR||SMLR||DHR / SMLR|
overvalued / fair valued / undervalued
PROFIT vs RISK RATING
PRICE GROWTH RATING
P/E GROWTH RATING
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SMLR's Valuation (66) in the Medical Specialties industry is in the same range as DHR (73). This means that SMLR’s stock grew similarly to DHR’s over the last 12 months.
DHR's Profit vs Risk Rating (14) in the Medical Specialties industry is significantly better than the same rating for SMLR (100). This means that DHR’s stock grew significantly faster than SMLR’s over the last 12 months.
SMLR's SMR Rating (33) in the Medical Specialties industry is in the same range as DHR (62). This means that SMLR’s stock grew similarly to DHR’s over the last 12 months.
DHR's Price Growth Rating (56) in the Medical Specialties industry is in the same range as SMLR (57). This means that DHR’s stock grew similarly to SMLR’s over the last 12 months.
DHR's P/E Growth Rating (65) in the Medical Specialties industry is in the same range as SMLR (91). This means that DHR’s stock grew similarly to SMLR’s over the last 12 months.
1 day ago55%
1 day ago67%
1 day ago76%
1 day ago56%
1 day ago77%
1 day ago60%
1 day ago69%
1 day ago56%
1 day ago73%
1 day ago53%
1 day ago68%
16 days ago63%
3 days ago82%
9 days ago54%
5 days ago75%
3 days ago49%
1 day ago76%
1 day ago80%
A.I.dvisor tells us that SMLR and CHEK have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SMLR and CHEK's prices will move in lockstep.